New NYU Langone trial shows role of drug + CI-PCM care in Alzheimer's

A new trial conducted by NYU Langone Medical Centre in the US has demonstrated a favourable outcome with the combination of a common Alzheimer's disease drug and a specific care management programme.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news